TITLE

The insertion/deletion variation in the α2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes

AUTHOR(S)
Snapir, Amir; Scheinin, Mika; Groop, Leif C.; Orho-Melander, Marju
PUB. DATE
January 2003
SOURCE
Cardiovascular Diabetology;2003, Vol. 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: An insertion/deletion polymorphism in the α2B-adrenoceptor (AR) has been associated with the risk for acute myocardial infarction (AMI) and sudden cardiac death. In this study we tested whether this polymorphism is associated with the risk for AMI among members of families with type 2 diabetes. Methods: 154 subjects with a history of AMI were matched for age and sex with one of their siblings who did not have a history of AMI. The prevalence of the genotypes of the α2B-AR insertion/deletion polymorphism was compared between the siblings using McNemar's test. We also explored the data to see whether this genetic variation affects the risk for hypertension by using logistic regression models in the two subpopulations of subjects, with and without a history of AMI. Results: Among all study subjects, 73 (24%) carried the α2B-AR deletion/deletion genotype, 103 (33%) carried the insertion/insertion genotype, and 132 (43%) were heterozygous. The distribution of genotypes of the α2B-AR insertion/deletion variation in the group of subjects with a history of AMI and their phenotype-discordant siblings did not statistically significantly differ from that expected by random distribution (p = 0.52): the deletion/deletion genotype was carried by 34 subjects with AMI (22%), and by 39 subjects without AMI (25%). Neither did we observe any significant difference in deletion allele frequencies of the α2B-AR insertion/deletion polymorphism between patients with a history of AMI (0.44) and their sib-pair controls (0.46, p = 0.65). In an exploratory analysis, the α2B-AR deletion/deletion genotype was associated with increased odds for hypertension compared with subjects carrying any of the other genotypes.
ACCESSION #
28683662

 

Related Articles

  • Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects. Hadjadj, Samy; Fumeron, Frédéric; Roussel, Ronan; Saulnier, Pierre-Jean; Gallois, Yves; Ankotche, Amos; Travert, Florence; Khalil, Charbel Abi; Miot, Aurélie; Alhenc-Gelas, François; Lievre, Michel; Marre, Michel // Diabetes Care;Sep2008, Vol. 31 Issue 9, p1847 

    OBJECTIVE -- We tested whether determination of the ACE insertion/deletion polymorphism is useful for renal and cardiovascular prognoses of type 2 diabetic subjects. RESEARCH DESIGN AND METHODS -- The French participants (3,126 of 4,912) in the Non-Insulin-Dependent Diabetes, Hypertension,...

  • Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension: A Randomized Controlled Trial. Bakris, George L.; Fonseca, Vivian; Katholi, Richard E.; McGill, Janet B.; Messerli, Franz H.; Phillips, Robert A.; Raskin, Philip; Wright, Jackson T.; Oakes, Rosemary; Lukas, Mary Ann; Anderson, Karen M.; Bell, David S. H. // JAMA: Journal of the American Medical Association;11/10/2004, Vol. 292 Issue 18, p2227 

    Context β-Blockers have been shown to decrease cardiovascular risk in patients with hypertension and type 2 diabetes mellitus (DM); however, some components of the metabolic syndrome are worsened by some β-blockers. Objective To compare the effects of β-blockers with different...

  • Human Urotensin II Promotes Hypertension and Atherosclerotic Cardiovascular Diseases. Watanabe, Takuya; Arita, Shigeko; Shiraishi, Yuji; Suguro, Toshiaki; Sakai, Tetsuo; Hongo, Shigeki; Miyasaki, Akira // Current Medicinal Chemistry;Feb2009, Vol. 16 Issue 5, p550 

    Human urotensin II (U-II), the most potent vasoconstrictor undecapeptide identified to date, and its receptor (UT) are involved in the pathogenesis of systemic and pulmonary hypertension. Here, we review recent advances in our understanding of the pathophysiology of U-II with particular...

  • Enzymatic and genetic polymorphisms of paraoxonase-1 in the Gabonese population: the relation to lipid parameters in patients with diabetes. Abessolo, F. A.; Bruno, M. J.; N'negue, M. A.; Yangou, M.; Ngou-Milama, E. // Journal of Endocrinology, Metabolism & Diabetes of South Africa;Jun2012, Vol. 17 Issue 2, p92 

    Background: The objective was to study the relationship between the paraoxonase-1 activity, genetic polymorphisms and lipid parameters in a black patient population. Method: This study investigates patients with type 2 diabetes and hypertension for which concentrations of total high-density...

  • Association of deletion allele of insertion/deletion polymorphism in a2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus. Tayel, Safaa I.; Khader, Heba F.; El-Helbawy, Nesreen G.; Ibrahim, Waleed A. // Application of Clinical Genetics;2012 Part 2, Vol. 5, p111 

    Background: Vascular a2B-adrenoreceptors have the potential to increase blood pressure by mediating vasoconstriction. A nine-nucleotide deletion in the receptor enhances vasoconstriction and exacerbates hypertension. The aim of this study was to determine the association between...

  • Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families. Muñoz-Barrios, Salvador; Guzmán-Guzmán, Iris Paola; José Francisco; Salgado-Bernabé, Aralia Berenice; Salgado-Goytia, Lorenzo; Parra-Rojas, Isela // Disease Markers;2012, Vol. 33 Issue 6, p313 

    Lipoprotein lipase (LPL) is a key enzyme in lipid metabolism and is associated with obesity, dyslipidemias, hypertension (HTN) and type 2 diabetes mellitus (T2DM). LPL gene polymorphisms can be related with the development of cardiovascular risk factors. The present study was conducted to...

  • Increased frequency of G-protein β[sub 3]-subunit 825 T allele in dialyzed patients with type 2 diabetes. Blüthner, Martin; Schmidt, Susanne; Siffert, Winfried; Knigge, Heidrun; Nawroth, Peter; Ritz, Eberhard // Kidney International;Apr1999, Vol. 55 Issue 4, p1247 

    Increased frequency of G-protein β3-subunit 825 T allele in dialyzed patients with type 2 diabetes. Background. A polymorphism (C825T) in exon 10 of the gene encoding the β3 subunit of heterotrimeric G proteins (GNβ3) has recently been described, and the T allele was found to be...

  • Association of G2350A Polymorphism of Angiotensin Converting Enzyme Gene with Essential Hypertension and Type 2 Diabetes Mellitus in Malaysian Subjects. Vasudevan, R.; Ismail, P.; Stanslas, J.; Shamsudin, N. // Journal of Biological Sciences;2008, Vol. 8 Issue 4, p1045 

    The objective of this study was to determine the association of Angiotensin-Converting Enzyme (ACE) G2350A polymorphism in Essential Hypertension (EHT) and Type 2 Diabetes Mellitus (T2DM) in Malaysian subjects. A total of 265 samples have been recruited for this study. In order to amplify the...

  • The α-Adducin Gene Is Associated With Macrovascular Complications and Mortality in Patients With Type 2 Diabetes. Yazdanpanah, Mojgan; Sayed-Tabatabaei, Fakhredin A.; Hofman, Albert; Aulchenko, Yurii S.; Oostra, Ben A.; Stricker, Bruno H. C.; Pols, Huibert A. P.; Lamberts, Steven W. J.; Witteman, Jacqueline C. M.; Janssen, Joop A. M. J. L.; van Duijn, Cornelia M. // Diabetes;Oct2006, Vol. 55 Issue 10, p2922 

    We examined the association between α-adducin 1 (ADD1) gene polymorphism (Gly460Trp) with macrovascular complications and mortality in type 2 diabetes in a Caucasian population aged ≥55 years. The study was part of the Rotterdam Study, a prospective population-based cohort study. ADD1...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics